SlideShare a Scribd company logo
Dr.Riyaz Sheriff M.D ….
IMMUNITY
IMMUNITY
INNATE
NON
SPECIFIC
SPECIES
RACE
INDIVIDUAL
SPECIFIC
SPECIES
RACE
INDIVIDUAL
ACQUIRED
ACTIVE
NATURAL
ARTIFICIAL
PASSIVE
NATURAL
ARTIFICIAL
ACQUIRED IMMUNITY
• Immunity which a person acquired during his
lifetime
• Not related to innate immunity
Acquired IMMUNITY
ACQUIRED
ACTIVE
NATURAL ARTIFICIAL
PASSIVE
NATURAL ARTIFICIAL
Acquired active
IMMUNITY
ACQUIRED
ACTIVE
NATURAL ARTIFICIAL
Resistance developed as a result of
antigenic stimulus
Also called “Adaptive Immunity”
Active involvement of host immune
apparatus
Leads to production of antibodies /
Immunologically active cells
Takes time to set in after infection
Acquired active
IMMUNITY
ACQUIRED
ACTIVE
NATURAL ARTIFICIAL
Initial NEGATIVE PHASE : The
level of measureable immunity is
lower than it was before exposure to
antigen.
The antigen combines with the
existing antibody leading to reduction
in existing levels of antibody.
Acquired active IMMUNITY
ACQUIRED
ACTIVE
NATURAL ARTIFICIAL
Once active immunity sets in
It is long lasting
One second exposure to same antigen the
immune response is quick and abundant
:SECONDARY RESPONSE
Development of humoral & cellular
immunity
Immunological memory
Active immunization is more effective and
confers better protection
May be Natural or Artificial
Natural active IMMUNITY
 May be as a result of clinical or inapparent infection
 Measles infection gives the patient life long immunity
 Adults in developing countries have natural active immunity against
polio because of inapparent infections in childhood
 Duration of immunity depends on the pathogen
 Short term – Eg. Influenza
 Long term - Eg. Measeles , chicken pox
 Why common cold does not provide us immunity ???
Antigenic
variation
natural active IMMUNITY
 Bacterial infections provide with less degree of
immunity
 PREMUNITION – Seen in syphilis . The immunity to
reinfections lasts only till the original infection is
active.
 Chancroid does not provide the person with any
immunity . Person may develop lesions following
reinfection even when original infection is active.
Artificial active immunity
• Resistance induced by vaccines
• Vaccines are preparations of live or killed
microorganisms or their products used for
immunization
• Bacterial vaccines
– Live : BCG vaccine
– Killed: Cholera vaccine
– Subunit : Typhoid Vi antigen
– Bacterial products: Tetanus toxoid
• Viral vaccines
– Live : OPV-Sabin
– Killed : IPV – Salk
– Subunit : Hepatitis B Vaccine
Vaccines
LIVE VACCINES
• Infection without disease
• Immunity lasts for several
years
• Booster doses MAY BE
needed
• Can be given orally or
parenterally
KILLED VACCINES
• No infective stage
• Less immunogenic
• Repeated doses needed
– Primary dose
– Booster dose
• Oral doses not effective
• Parenteral doses given with
adjuvant to increase
humoral immunity
Passive immunity
o No infection
o Readymade antibodies are
administered
o No latent period
o No negative phase
o Immediate protection
o Immunity lasts for short
duration till antibodies are
metabolized
o No secondary response
o Passive immunity decreases
with repetition
Types of passive acquired
immunity PASSIVE
NATURAL ARTIFICIAL
Resistance transferred from mother to baby
Via placenta
Breast milk – colostrum – IgA
IgM production by fetus can start from 20th week of intrauterine life
Inadequate immunity at birth
By 3 months of age – immunological independence
• < 3 months – Pediatric infections are common
Active immunization of mother provides passive immunity to infants
Eg. Tetanus toxoid during pregnancy
Types of passive acquired
immunity PASSIVE
NATURAL ARTIFICIALResistance transferred by
administration of antibodies
Hyper immune sera
Convalescent sera
Pooled human Ɣ globulin
Used for prophylaxis and therapy
Hyperimmune sera
• Anti-tetanus serum (ATS)
• Prepared from hyperimmunized horses
• Temporary protection
• Disadvantages
• Hypersensitivity
• Immune elimination
• In use
– Hyperimmune globulin of human origin
Animal origin in use
Anti-Gas gangrene sera
Anti-Botulinum sera
Antivenoms
Convalescent sera
• Sera of patients recovering from disease
• Contain high levels of antibody specific to the disease
• Use – Viral infections like Hepatitis A
Pooled human Ɣ globulin
• Ɣ globulin from pooled sera of healthy adults
• Has antibodies to all pathogens prevalent in the area
• Use – Rx of patients with immunodeficiencies
Indications for passive
immunization
• Immediate and temporary protection of a
person at risk of developing infection
• To arrest overactive active immunity
Eg. Rh incompatibility
Combined immunization
• Combination of active and passive methods
• Passive immunization for immediate
protection
• Tetanus
• TIG in one arm + TT in other arm
• Followed by complete schedule of tetanus
vaccination
Adoptive immunity
• Special type of immunization
• Injection of immunologically competent
lymphocytes  TRANSFER FACTOR
• Tried in treatment of Lepromatous Leprosy
Local immunity
• Besredka
• Treatment of infections in a localized area
• Polio –
– Systemic immunity by IPV
• Does not prevent multiplication of virus in the gut
– This is achieved by OPV
• Influenza
– Killed vaccine brings about a humoral response
• Not enough to prevent infection
• Intra nasal live virus injection/ natural infection provides
local immunity
– IgA
Immunoglobulin A (IgA)
• Secretory IgA
• Produced locally by plasma cells on mucosal
surfaces / Secretory glands
• With exposure to an antigen
Specific IgA is produced
• Mucosal defense
• Handling of antigens contracted from food and
external environment
Herd immunity
 Overall immunity in a community
 Useful in control of epidemics
• When LARGE NUMBER of people in a community are
immune to a specific pathogen Herd immunity is
SATISFACTORY
• Eradication of communicable disease lies in development of
good herd immunity rather than developing individual
immunity
Measurement of immunity
• Practically not possible to measure accurately
• Simple method is to demonstrate the presence of a
specific antibody
– Not reliable as one pathogen will illicit immune response to
multiple antigens
• Antibody demonstration
– Agglutination
– Precipitation
– Complement fixation
– Hemagglutination inhibition
– Neutralization
– ELISA
• If antigenic component is identified in-vitro or
in-vivo assays can be done.
• If immunity is associated with cell mediated
immunity
– Skin tests for delayed hypersensitivity
– In-vitro tests for Cell mediated immunity
Measurement of immunity
Acquired immunity

More Related Content

What's hot

Antigen and antibody reaction
Antigen and antibody reactionAntigen and antibody reaction
Antigen and antibody reaction
Rachana Tiwari
 

What's hot (20)

Antibodies
AntibodiesAntibodies
Antibodies
 
Hypersensitity, And Types of Hypersensitivity I, II, III, IV
Hypersensitity, And Types of Hypersensitivity I, II, III, IVHypersensitity, And Types of Hypersensitivity I, II, III, IV
Hypersensitity, And Types of Hypersensitivity I, II, III, IV
 
Humoral immunity
Humoral immunityHumoral immunity
Humoral immunity
 
Cell mediated immunity
Cell mediated immunityCell mediated immunity
Cell mediated immunity
 
T-lymphocytes and generation
T-lymphocytes and generationT-lymphocytes and generation
T-lymphocytes and generation
 
Adaptive immunity
Adaptive immunityAdaptive immunity
Adaptive immunity
 
Active and passive immunity
Active and passive immunityActive and passive immunity
Active and passive immunity
 
IMMUNITY
IMMUNITYIMMUNITY
IMMUNITY
 
Final type-iv hypersensityvity
Final type-iv hypersensityvityFinal type-iv hypersensityvity
Final type-iv hypersensityvity
 
Immune response
Immune responseImmune response
Immune response
 
ANTIGEN ( IMMUNOLOGY-1)
ANTIGEN ( IMMUNOLOGY-1)ANTIGEN ( IMMUNOLOGY-1)
ANTIGEN ( IMMUNOLOGY-1)
 
Antigen
AntigenAntigen
Antigen
 
Vaccines
VaccinesVaccines
Vaccines
 
Immunoglobulins
ImmunoglobulinsImmunoglobulins
Immunoglobulins
 
Type II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
Type II Hypersensitivity-Antibody mediated cytotoxic HypersensitivityType II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
Type II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
 
Types of immunity
Types of immunityTypes of immunity
Types of immunity
 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
 
Antigen and antibody reaction
Antigen and antibody reactionAntigen and antibody reaction
Antigen and antibody reaction
 
Antigens
AntigensAntigens
Antigens
 
Phagocytosis
PhagocytosisPhagocytosis
Phagocytosis
 

Similar to Acquired immunity

1 Immunization.pptjjjjjjjhgjfxfffffddddd
1 Immunization.pptjjjjjjjhgjfxfffffddddd1 Immunization.pptjjjjjjjhgjfxfffffddddd
1 Immunization.pptjjjjjjjhgjfxfffffddddd
imnetuy
 

Similar to Acquired immunity (20)

10 Immunity . ಇಂದ ಗೌತಮ್ ಕನ್ನಡಿಗ
10 Immunity . ಇಂದ ಗೌತಮ್  ಕನ್ನಡಿಗ 10 Immunity . ಇಂದ ಗೌತಮ್  ಕನ್ನಡಿಗ
10 Immunity . ಇಂದ ಗೌತಮ್ ಕನ್ನಡಿಗ
 
vaccinatoin ppt.ppt
vaccinatoin ppt.pptvaccinatoin ppt.ppt
vaccinatoin ppt.ppt
 
Active and passive immunisation.pptx
Active and passive immunisation.pptxActive and passive immunisation.pptx
Active and passive immunisation.pptx
 
IMMUNIZATION AND VACCINES-1.pptx
IMMUNIZATION AND VACCINES-1.pptxIMMUNIZATION AND VACCINES-1.pptx
IMMUNIZATION AND VACCINES-1.pptx
 
Principles of Vaccination
Principles of VaccinationPrinciples of Vaccination
Principles of Vaccination
 
immunity-150818184151-lva1-app6892-converted.pptx
immunity-150818184151-lva1-app6892-converted.pptximmunity-150818184151-lva1-app6892-converted.pptx
immunity-150818184151-lva1-app6892-converted.pptx
 
Immunity
ImmunityImmunity
Immunity
 
IMMUNI PART 1.pptx
IMMUNI PART 1.pptxIMMUNI PART 1.pptx
IMMUNI PART 1.pptx
 
Vaccination: how vaccination helps to prevent diseases
Vaccination: how vaccination helps to prevent diseasesVaccination: how vaccination helps to prevent diseases
Vaccination: how vaccination helps to prevent diseases
 
Immunity
ImmunityImmunity
Immunity
 
IMMUNITY.pptx
IMMUNITY.pptxIMMUNITY.pptx
IMMUNITY.pptx
 
Adaptive immunity (1).pptx
Adaptive immunity (1).pptxAdaptive immunity (1).pptx
Adaptive immunity (1).pptx
 
Vaccine-1.pptx
Vaccine-1.pptxVaccine-1.pptx
Vaccine-1.pptx
 
Vaccines
VaccinesVaccines
Vaccines
 
Paediatric immunization
Paediatric immunizationPaediatric immunization
Paediatric immunization
 
Paediatric immunization
Paediatric immunizationPaediatric immunization
Paediatric immunization
 
Active and Passive Immunization.pptx
Active and Passive Immunization.pptxActive and Passive Immunization.pptx
Active and Passive Immunization.pptx
 
1 Immunization.pptjjjjjjjhgjfxfffffddddd
1 Immunization.pptjjjjjjjhgjfxfffffddddd1 Immunization.pptjjjjjjjhgjfxfffffddddd
1 Immunization.pptjjjjjjjhgjfxfffffddddd
 
Immunity
ImmunityImmunity
Immunity
 
Immunity and immunizing agent...........
Immunity and immunizing agent...........Immunity and immunizing agent...........
Immunity and immunizing agent...........
 

More from Riyaz Sheriff (13)

Complement system
Complement systemComplement system
Complement system
 
Staphylococcus
Staphylococcus Staphylococcus
Staphylococcus
 
RICKETTSIACEAE
RICKETTSIACEAERICKETTSIACEAE
RICKETTSIACEAE
 
Tuberculosis 2
Tuberculosis 2 Tuberculosis 2
Tuberculosis 2
 
Viral host interactions
Viral host interactionsViral host interactions
Viral host interactions
 
Yersinia pasteurella fransicella
Yersinia pasteurella fransicellaYersinia pasteurella fransicella
Yersinia pasteurella fransicella
 
Virology intro 1
Virology intro 1Virology intro 1
Virology intro 1
 
Ascaris lumbricoides
Ascaris lumbricoidesAscaris lumbricoides
Ascaris lumbricoides
 
Spirochetes for undergraduate students. treponema, leptospira, borrelia
Spirochetes for undergraduate students. treponema, leptospira, borreliaSpirochetes for undergraduate students. treponema, leptospira, borrelia
Spirochetes for undergraduate students. treponema, leptospira, borrelia
 
Microscopy
MicroscopyMicroscopy
Microscopy
 
Enterococci
EnterococciEnterococci
Enterococci
 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
 
MRSA
MRSAMRSA
MRSA
 

Recently uploaded

Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
DanielOliver74
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
Integrated Mother and Neonate Childwood Illness Health Care
Integrated Mother and Neonate Childwood Illness  Health CareIntegrated Mother and Neonate Childwood Illness  Health Care
Integrated Mother and Neonate Childwood Illness Health Care
ASKatoch1
 

Recently uploaded (20)

PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptxPhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
 
What can we really do to give meaning and momentum to equality, diversity and...
What can we really do to give meaning and momentum to equality, diversity and...What can we really do to give meaning and momentum to equality, diversity and...
What can we really do to give meaning and momentum to equality, diversity and...
 
Enhancing-Patient-Centric-Clinical-Trials.pdf
Enhancing-Patient-Centric-Clinical-Trials.pdfEnhancing-Patient-Centric-Clinical-Trials.pdf
Enhancing-Patient-Centric-Clinical-Trials.pdf
 
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdfCHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
 
Sugar Medicine_ Natural Homeopathy Remedies for Blood Sugar Management.pdf
Sugar Medicine_ Natural Homeopathy Remedies for Blood Sugar Management.pdfSugar Medicine_ Natural Homeopathy Remedies for Blood Sugar Management.pdf
Sugar Medicine_ Natural Homeopathy Remedies for Blood Sugar Management.pdf
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
Jaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model Safe
Jaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model SafeJaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model Safe
Jaipur @ℂall @Girls ꧁❤8901183002❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx
Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptxNose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx
Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx
 
pathology seminar presentation best ppt by .pptx
pathology seminar presentation best ppt by  .pptxpathology seminar presentation best ppt by  .pptx
pathology seminar presentation best ppt by .pptx
 
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdfCHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
Occupational Therapy Management for Parkinson's Disease - Webinar 2024
Occupational Therapy Management for Parkinson's Disease - Webinar 2024Occupational Therapy Management for Parkinson's Disease - Webinar 2024
Occupational Therapy Management for Parkinson's Disease - Webinar 2024
 
#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...
#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...
#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...
 
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts by ✔️🍑💃Hotel #cALL #gIRLS...
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts  by ✔️🍑💃Hotel #cALL #gIRLS...💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts  by ✔️🍑💃Hotel #cALL #gIRLS...
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts by ✔️🍑💃Hotel #cALL #gIRLS...
 
Integrated Mother and Neonate Childwood Illness Health Care
Integrated Mother and Neonate Childwood Illness  Health CareIntegrated Mother and Neonate Childwood Illness  Health Care
Integrated Mother and Neonate Childwood Illness Health Care
 
Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...
Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...
Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 

Acquired immunity

  • 3. ACQUIRED IMMUNITY • Immunity which a person acquired during his lifetime • Not related to innate immunity
  • 5. Acquired active IMMUNITY ACQUIRED ACTIVE NATURAL ARTIFICIAL Resistance developed as a result of antigenic stimulus Also called “Adaptive Immunity” Active involvement of host immune apparatus Leads to production of antibodies / Immunologically active cells Takes time to set in after infection
  • 6. Acquired active IMMUNITY ACQUIRED ACTIVE NATURAL ARTIFICIAL Initial NEGATIVE PHASE : The level of measureable immunity is lower than it was before exposure to antigen. The antigen combines with the existing antibody leading to reduction in existing levels of antibody.
  • 7. Acquired active IMMUNITY ACQUIRED ACTIVE NATURAL ARTIFICIAL Once active immunity sets in It is long lasting One second exposure to same antigen the immune response is quick and abundant :SECONDARY RESPONSE Development of humoral & cellular immunity Immunological memory Active immunization is more effective and confers better protection May be Natural or Artificial
  • 8. Natural active IMMUNITY  May be as a result of clinical or inapparent infection  Measles infection gives the patient life long immunity  Adults in developing countries have natural active immunity against polio because of inapparent infections in childhood  Duration of immunity depends on the pathogen  Short term – Eg. Influenza  Long term - Eg. Measeles , chicken pox  Why common cold does not provide us immunity ??? Antigenic variation
  • 9. natural active IMMUNITY  Bacterial infections provide with less degree of immunity  PREMUNITION – Seen in syphilis . The immunity to reinfections lasts only till the original infection is active.  Chancroid does not provide the person with any immunity . Person may develop lesions following reinfection even when original infection is active.
  • 10. Artificial active immunity • Resistance induced by vaccines • Vaccines are preparations of live or killed microorganisms or their products used for immunization • Bacterial vaccines – Live : BCG vaccine – Killed: Cholera vaccine – Subunit : Typhoid Vi antigen – Bacterial products: Tetanus toxoid • Viral vaccines – Live : OPV-Sabin – Killed : IPV – Salk – Subunit : Hepatitis B Vaccine
  • 11. Vaccines LIVE VACCINES • Infection without disease • Immunity lasts for several years • Booster doses MAY BE needed • Can be given orally or parenterally KILLED VACCINES • No infective stage • Less immunogenic • Repeated doses needed – Primary dose – Booster dose • Oral doses not effective • Parenteral doses given with adjuvant to increase humoral immunity
  • 12. Passive immunity o No infection o Readymade antibodies are administered o No latent period o No negative phase o Immediate protection o Immunity lasts for short duration till antibodies are metabolized o No secondary response o Passive immunity decreases with repetition
  • 13. Types of passive acquired immunity PASSIVE NATURAL ARTIFICIAL Resistance transferred from mother to baby Via placenta Breast milk – colostrum – IgA IgM production by fetus can start from 20th week of intrauterine life Inadequate immunity at birth By 3 months of age – immunological independence • < 3 months – Pediatric infections are common Active immunization of mother provides passive immunity to infants Eg. Tetanus toxoid during pregnancy
  • 14. Types of passive acquired immunity PASSIVE NATURAL ARTIFICIALResistance transferred by administration of antibodies Hyper immune sera Convalescent sera Pooled human Ɣ globulin Used for prophylaxis and therapy
  • 15. Hyperimmune sera • Anti-tetanus serum (ATS) • Prepared from hyperimmunized horses • Temporary protection • Disadvantages • Hypersensitivity • Immune elimination • In use – Hyperimmune globulin of human origin Animal origin in use Anti-Gas gangrene sera Anti-Botulinum sera Antivenoms
  • 16. Convalescent sera • Sera of patients recovering from disease • Contain high levels of antibody specific to the disease • Use – Viral infections like Hepatitis A Pooled human Ɣ globulin • Ɣ globulin from pooled sera of healthy adults • Has antibodies to all pathogens prevalent in the area • Use – Rx of patients with immunodeficiencies
  • 17. Indications for passive immunization • Immediate and temporary protection of a person at risk of developing infection • To arrest overactive active immunity Eg. Rh incompatibility
  • 18. Combined immunization • Combination of active and passive methods • Passive immunization for immediate protection • Tetanus • TIG in one arm + TT in other arm • Followed by complete schedule of tetanus vaccination
  • 19. Adoptive immunity • Special type of immunization • Injection of immunologically competent lymphocytes  TRANSFER FACTOR • Tried in treatment of Lepromatous Leprosy
  • 20. Local immunity • Besredka • Treatment of infections in a localized area • Polio – – Systemic immunity by IPV • Does not prevent multiplication of virus in the gut – This is achieved by OPV • Influenza – Killed vaccine brings about a humoral response • Not enough to prevent infection • Intra nasal live virus injection/ natural infection provides local immunity – IgA
  • 21. Immunoglobulin A (IgA) • Secretory IgA • Produced locally by plasma cells on mucosal surfaces / Secretory glands • With exposure to an antigen Specific IgA is produced • Mucosal defense • Handling of antigens contracted from food and external environment
  • 22. Herd immunity  Overall immunity in a community  Useful in control of epidemics • When LARGE NUMBER of people in a community are immune to a specific pathogen Herd immunity is SATISFACTORY • Eradication of communicable disease lies in development of good herd immunity rather than developing individual immunity
  • 23. Measurement of immunity • Practically not possible to measure accurately • Simple method is to demonstrate the presence of a specific antibody – Not reliable as one pathogen will illicit immune response to multiple antigens • Antibody demonstration – Agglutination – Precipitation – Complement fixation – Hemagglutination inhibition – Neutralization – ELISA
  • 24. • If antigenic component is identified in-vitro or in-vivo assays can be done. • If immunity is associated with cell mediated immunity – Skin tests for delayed hypersensitivity – In-vitro tests for Cell mediated immunity Measurement of immunity